Treatments for COVID-19: emerging drugs against the coronavirus

Treatments for COVID-19: emerging drugs against the coronavirus

Authors

  • Sara Khademolhosseini Department of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  • Hadiseh Kavandi Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Samad Ghaffari Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Keywords:

COVID-19 , Reserpine , COPB2

Abstract

N/A

References

Potì F, Pozzoli C, Adami M, Poli E, Costa LG. Treatments for COVID-19: emerging drugs against the coronavirus. Acta Bio-Medica Atenei Parm. 2020 May 11;91(2):118–36.

Duarte RRR, Copertino Jr. DC, Iñiguez LP, Marston JL, Nixon DF, Powell TR. Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach. 2020 Apr 21 [cited 2020 Jun 2]; Available from: https://chemrxiv.org/articles/Repurposing_FDA-Approved_Drugs_for_COVID-19_Using_a_Data-Driven_Approach/12148764

Wilde AH de, Wannee KF, Scholte FEM et al. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins. J Virol. 2015 Aug 15;89(16):8318–33.

Avchaciov K, Burmistrova O, Fedichev PO. AI for the repurposing of approved or investigational drugs against COVID-19. Res Gate Doi Doi. 2020;10.

Wu C-Y, Jan J-T, Ma S-H et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci. 2004 Jul 6;101(27):10012–7.

Downloads

Published

07-09-2020

Issue

Section

CORRESPONDENCE/CASE REPORTS - SPECIAL COVID19

How to Cite

1.
Khademolhosseini S, Kavandi H, Ghaffari S. Treatments for COVID-19: emerging drugs against the coronavirus. Acta Biomed [Internet]. 2020 Sep. 7 [cited 2024 Jul. 24];91(3):e2020048. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9982